Patients News | pharmaphorum

News

The EMA has become the first regulator to link the use of Novo Nordisk's GLP-1 agonist semaglutide with sight-robbing disorder NAION.

News

The NHS is said to be in line for a £30bn increase to its budget in the upcoming spending review, but some are concerned it will not be enough.

News

Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.

News

A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron.

News

Women in the UK taking weight-loss injections have been warned by the MHRA that they should make sure they are using effective contraception.

News

With new guidance, the EMA is seeking to ramp up the inclusion of pregnant and breastfeeding women in clinical trials.